Straits Times Index
3,318.45 +1.89 (+0.06%) S&P 500
5,304.72 +36.88 (+0.70%) Dow
39,069.59 +4.29 (+0.01%) Nasdaq
16,920.79 +184.79 (+1.10%) Bitcoin USD
69,471.08 +976.71 (+1.43%) CMC Crypto 200
1,497.01 +12.81 (+0.86%)
Fresenius SE & Co. KGaA (FSNUF)
| Previous close | 28.66 |
| Open | 32.58 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 32.58 - 32.58 |
| 52-week range | 25.77 - 32.58 |
| Volume | |
| Avg. volume | 470 |
| Market cap | 18.352B |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | 47.92 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.99 (3.26%) |
| Ex-dividend date | 18 May 2023 |
| 1y target est | N/A |
- Simply Wall St.
Investors five-year losses continue as Fresenius SE KGaA (ETR:FRE) dips a further 3.8% this week, earnings continue to decline
The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results...
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
- Simply Wall St.
Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
Key Insights Fresenius SE KGaA's significant retail investors ownership suggests that the key decisions are influenced...
